Tag: nanomedicine
-
Breakthrough Eye Drop Nanomedicine Secures Worldwide Patents
Breakthrough in Eye Care: International Patents for Nanomedicine Eye Drops In a landmark development for ophthalmology and patient care, SETU Researcher Dr. Laurence Fitzhenry and the Ocular Therapeutics Research Group (OTRG) at South East Technological University have secured two international patents for advanced eye drop technology. Granted by the United States and European patent offices,…
-
SETU Researcher Secures International Patents for Breakthrough Eye Drop Technology
SETU researcher earns international patents for revolutionary eye drop technology The healthcare and biotech communities are celebrating after Dr. Laurence Fitzhenry of South East Technological University (SETU) secured two international patents for groundbreaking eye drop technologies. Awarded by both the United States and European patent offices, the patents cover a new generation of nanomedicine eye…
-
Nanomedicine Emerges as a Key Tool to Boost Cancer Immunotherapy
Nanomedicine and Immunotherapy: A New Synergy The landscape of cancer treatment is rapidly evolving as researchers explore how nanotechnology can complement and strengthen immunotherapy. Recent back-to-back reviews in Nature Cancer and Trends in Cancer highlight nanomedicine as a versatile approach to reprogram the immune system and overcome the immune evasion strategies employed by solid tumors.…
-
Nanomedicine Boosts Cancer Immunotherapy: Reprogramming the Immune Fight
Nanomedicine Emerges as a Key Tool in Cancer Immunotherapy Researchers at the Fralin Biomedical Research Institute at Virginia Tech (VTC) and their collaborators are exploring how nanotechnology and immunology intersect to enhance cancer immunotherapy. Recent back-to-back review articles published in Nature Cancer and Trends in Cancer synthesize current insights on how nanoengineering can reprogram the…
-
World-first LAF assay reveals hidden interactions in blood
World-first LAF assay: a new lens on blood chemistry A team at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has unveiled a world-first assay that rapidly measures interactions between nanoscale particles in the bloodstream. The lipoprotein association fluorometry (LAF) technique can deliver results in about one hour, a dramatic improvement over…
-
World-first LAF assay reveals hidden blood particle interactions
Breakthrough in Blood Biology: The LAF Assay A team at the Australian Institute for Bioengineering and Nanotechnology (AIBN) has unveiled a world-first assay that can measure interactions between tiny particles in the bloodstream in just one hour. Lipoprotein association fluorometry, or LAF, was developed by PhD student Raluca Ghebosu under the supervision of AIBN’s Joy…
-
World-first LAF Assay Reveals Hidden Blood Interactions in Cancer
World-first LAF assay accelerates cancer research A groundbreaking technique developed at the Australian Institute for Bioengineering and Nanotechnology (AIBN) is redefining how scientists study the bloodstream’s tiniest particles. Lipoprotein Association Fluorometry (LAF) is a world-first assay that can rapidly measure interactions between extracellular vesicles (EVs) and lipoproteins—crucial steps in understanding how cancers develop, spread, and…